Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cytochrome P450 Enzymes: A Review on Drug Metabolizing Enzyme Inhibition Studies in Drug Discovery and Development
Siva Nageswara Rao Gajula, Megha Pillai, Gananadhamu Samanthula, et al.
Bioanalysis (2021) Vol. 13, Iss. 17, pp. 1355-1378
Closed Access | Times Cited: 25

Showing 25 citing articles:

Role of the Synergistic Interactions of Environmental Pollutants in the Development of Cancer
Francisco Alejandro Lagunas‐Rangel, Jenni Viivi Linnea‐Niemi, Błażej Kudłak, et al.
GeoHealth (2022) Vol. 6, Iss. 4
Open Access | Times Cited: 37
From Complexity to Clarity: Expanding Metabolome Coverage With Innovative Analytical Strategies
Kanukolanu Aarika, Ramijinni Rajyalakshmi, Lakshmi Vineela Nalla, et al.
Journal of Separation Science (2025) Vol. 48, Iss. 2
Open Access
LC-MS/MS: A sensitive and selective analytical technique to detect COVID-19 protein biomarkers in the early disease stage
Siva Nageswara Rao Gajula, Ankita Sahebrao Khairnar, Pallavi Jock, et al.
Expert Review of Proteomics (2023) Vol. 20, Iss. 1-3, pp. 5-18
Closed Access | Times Cited: 11
The Hazard index at thirty-seven: New science new insights
Paul S. Price
Current Opinion in Toxicology (2023) Vol. 34, pp. 100388-100388
Closed Access | Times Cited: 9
Evaluation of novel pyrazol-4-yl pyridine derivatives possessing arylsulfonamide tethers as c-Jun N-terminal kinase (JNK) inhibitors in leukemia cells
Karim I. Mersal, Mohammed S. Abdel‐Maksoud, Eslam M.H. Ali, et al.
European Journal of Medicinal Chemistry (2023) Vol. 261, pp. 115779-115779
Closed Access | Times Cited: 9
Aldehyde oxidase mediated drug metabolism: an underpredicted obstacle in drug discovery and development
Siva Nageswara Rao Gajula, Tanaaz Navin Nathani, Rashmi Madhukar Patil, et al.
Drug Metabolism Reviews (2022) Vol. 54, Iss. 4, pp. 427-448
Closed Access | Times Cited: 14
The binding of nitrogen-donor ligands to the ferric and ferrous forms of cytochrome P450 enzymes
Hebatalla Mohamed, Amna Ghith, Stephen G. Bell
Journal of Inorganic Biochemistry (2023) Vol. 242, pp. 112168-112168
Closed Access | Times Cited: 6
A uniquein vivopharmacokinetic profile,in vitrometabolic stability and hepatic first-pass metabolism of garcinol, a promising novel anticancer phytoconstituent, by liquid chromatography–mass spectrometry
Siva Nageswara Rao Gajula, Sasikala Talari, Shrilekha Chilvery, et al.
RPS Pharmacy and Pharmacology Reports (2023) Vol. 2, Iss. 2
Open Access | Times Cited: 6
Electroanalysis of 4′-Hydroxydiclofenac for CYP2C9 Enzymatic Assay
Alexey V. Kuzikov, Tatiana A. Filippova, Rami A. Masamrekh, et al.
Electrocatalysis (2022) Vol. 13, Iss. 5, pp. 630-640
Closed Access | Times Cited: 9
In Silico Tools to Thaw the Complexity of the Data: Revolutionizing Drug Research in Drug Metabolism, Pharmacokinetics and Toxicity Prediction
Hema Sree Kommalapati, Pushpa Pilli, Vijaya Madhyanapu Golla, et al.
Current Drug Metabolism (2023) Vol. 24, Iss. 11, pp. 735-755
Closed Access | Times Cited: 4
Water Exchange from the Buried Binding Sites of Cytochrome P450 Enzymes 1A2, 2D6, and 3A4 Correlates with Conformational Fluctuations
Olgun Guvench
Molecules (2024) Vol. 29, Iss. 2, pp. 494-494
Open Access | Times Cited: 1
Nanoparticle‐Based mRNA Vaccines
Lakshmi Vineela Nalla, Siva Nageswara Rao Gajula, Vivek P. Chavda
(2024), pp. 275-303
Closed Access | Times Cited: 1
PHYSICOCHEMICAL AND PHARMACOKINETIC ANALYSIS AND DOCKING OF DRUG REPOSITIONING AGAINST SARS-COV-2: AN IN SILICO STUDY
Jackson A. Pereira, Eduardo Damasceno Costa
INDIAN DRUGS (2024) Vol. 61, Iss. 02, pp. 23-34
Closed Access | Times Cited: 1
Effect of Lipid Bilayer Anchoring on the Conformational Properties of the Cytochrome P450 2D6 Binding Site
Olgun Guvench
The Journal of Physical Chemistry B (2024)
Closed Access | Times Cited: 1
Excipient toxicity and safety
Vikas Pandey, Suryanarayana Polaka, Lakshmi Vineela Nalla, et al.
Elsevier eBooks (2022), pp. 487-511
Closed Access | Times Cited: 7
Green Bioanalysis: An Innovative and Eco-Friendly Approach for Analyzing Drugs in Biological Matrices
Siva Nageswara Rao Gajula, Nathani Tanaaz Navin, Sasikala Talari, et al.
Bioanalysis (2022) Vol. 14, Iss. 12, pp. 881-909
Closed Access | Times Cited: 7
Quantitative Structure-Activity Relationship, Structure-based Design, and ADMET studies of pyrimethamine and cycloguanil analogs inhibitors of Plasmodium falciparum dihydrofolate reductase-thymidylate synthase (PfDHFR-TS).
Zakari Ya’u Ibrahim, Adamu Uzairu, Gideon Adamu Shallangwa, et al.
Chemical Physics Impact (2022) Vol. 5, pp. 100132-100132
Open Access | Times Cited: 6
Development and Validation of a Proteomic Correlation Profiling Technique to Detect and Identify Enzymes Involved in Metabolism of Drugs of Concern
Takashi Kudo, Shiori Hashiba, Tatsuki Fukami, et al.
Drug Metabolism and Disposition (2023) Vol. 51, Iss. 7, pp. 824-832
Open Access | Times Cited: 3
Effect of chronopharmacology and food on in vivo pharmacokinetic profile of mavacamten
Siva Nageswara Rao Gajula, Sasikala Talari, Tanaaz Navin Nathani, et al.
Bioanalysis (2023) Vol. 15, Iss. 12, pp. 695-706
Closed Access | Times Cited: 3
Green sample preparation in bioanalysis: where are we now?
Hema Sree Kommalapati, Pushpa Pilli, Gananadhamu Samanthula
Bioanalysis (2023) Vol. 15, Iss. 7, pp. 363-366
Closed Access | Times Cited: 3
Exploring quinoline-type inhibitors of ergosterol biosynthesis: Binding mechanism investigation via molecular docking, pharmacophore mapping, and dynamics simulation approaches
Gustavo Adolfo Barraza, Julio R. Maza, Vladímir V. Kouznetsov, et al.
Computers in Biology and Medicine (2024) Vol. 185, pp. 109524-109524
Closed Access
Homology modeling, docking, and ADMET studies of benzoheterocyclic 4-aminoquinolines analogs as inhibitors of Plasmodium falciparum
Zakari Ya’u Ibrahim, Adamu Uzairu, Gideon Adamu Shallangwa, et al.
Journal of Taibah University Medical Sciences (2023) Vol. 18, Iss. 6, pp. 1200-1216
Open Access | Times Cited: 1
Chronopharmacokinetics: A Critical Missing Step in Drug Discovery and Development
Siva Nageswara Rao Gajula, Chandraiah Godugu, Rajesh Sonti
Bioanalysis (2023) Vol. 15, Iss. 8, pp. 421-424
Closed Access | Times Cited: 1
ZY12201: A Potent TGR5 Agonist: Identification of a Novel Pan CYP450 Inhibitor Tool Compound for In-Vitro Assessment
Poonam Giri, Lakshmikant Gupta, Anil Rathod, et al.
Drug Metabolism and Bioanalysis Letters (2022) Vol. 15, Iss. 2, pp. 116-132
Closed Access | Times Cited: 1
Quantitative Structure-Activity Relationship, Structure-Based Design, And ADMET Studies of Pyrimethamine and Cycloguanil Analogues Inhibitors of Plasmodium Falciparum Dihydrofolate Reductase-Thymidylate Synthase (Pf-DHFR-TS)
Zakari Ya’u Ibrahim, Adamu Uzairu, Gideon Adamu Shallangwa, et al.
SSRN Electronic Journal (2022)
Closed Access
Page 1

Scroll to top